WO2022131656A1 - Alkaloid-containing, water-soluble emulsified composition - Google Patents

Alkaloid-containing, water-soluble emulsified composition Download PDF

Info

Publication number
WO2022131656A1
WO2022131656A1 PCT/KR2021/018432 KR2021018432W WO2022131656A1 WO 2022131656 A1 WO2022131656 A1 WO 2022131656A1 KR 2021018432 W KR2021018432 W KR 2021018432W WO 2022131656 A1 WO2022131656 A1 WO 2022131656A1
Authority
WO
WIPO (PCT)
Prior art keywords
water
weight
emulsion
alkaloid
soluble
Prior art date
Application number
PCT/KR2021/018432
Other languages
French (fr)
Korean (ko)
Inventor
윤관식
Original Assignee
윤관식
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1020200174987A external-priority patent/KR102524312B1/en
Priority claimed from KR1020210026166A external-priority patent/KR20220122840A/en
Application filed by 윤관식 filed Critical 윤관식
Publication of WO2022131656A1 publication Critical patent/WO2022131656A1/en

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
    • A23D7/005—Edible oil or fat compositions containing an aqueous phase, e.g. margarines characterised by ingredients other than fatty acid triglycerides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
    • A23D7/01—Other fatty acid esters, e.g. phosphatides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
    • A23D9/007—Other edible oils or fats, e.g. shortenings, cooking oils characterised by ingredients other than fatty acid triglycerides
    • A23D9/013—Other fatty acid esters, e.g. phosphatides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
    • A23D9/06—Preservation of finished products
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts

Definitions

  • the present invention relates to an alkaloid-containing water-soluble emulsion composition containing a water-soluble antioxidant emulsion.
  • Alkaloids are basic compounds containing nitrogen, and are a generic term for organic compounds that exhibit strong pharmacological effects on humans and animals in relatively small amounts. .
  • alkaloids Most of the plants containing a large amount of alkaloids are known as medicinal herbs, and there are mainly tropical or subtropical plants. These alkaloids also have pharmacological and toxic effects. Caution is required when consuming.
  • ⁇ -Tocopherol is a representative natural antioxidant, widely distributed in seed oil, grains, and vegetables with green leaves.
  • vitamin E As vitamin E, it is a major fat-soluble antioxidant present in cell membranes and prevents oxidation of fat. .
  • Vitamin E can react directly with various oxygen radicals including peroxy radicals (ROO ⁇ ), CCl 3 , HO ⁇ as well as superoxide radicals (O 2 ⁇ ).
  • the antioxidant activity is high in the order of ⁇ > ⁇ > ⁇ > ⁇ .
  • ROO ⁇ peroxy radicals
  • CCl 3 CCl 3
  • HO ⁇ superoxide radicals
  • the antioxidant activity is high in the order of ⁇ > ⁇ > ⁇ > ⁇ .
  • polyunsaturated fatty acids composing cell membranes are easily oxidized by free radicals made in cells. Tocopherol stops this oxidation process and removes free radicals to protect cell membranes from oxidative damage.
  • An object of the present invention is to provide an alkaloid-containing water-soluble emulsion composition that not only can water-soluble functionally poorly soluble substances to increase the absorption rate and efficacy of the substances, but also has excellent oxidative stability in aqueous solution.
  • a water-soluble antioxidant emulsion comprising the following ingredients to satisfy 100% by weight of the total:
  • alkaloid-containing water-soluble emulsion composition containing a water-soluble antioxidant emulsion comprising a.
  • the water-soluble emulsion composition containing an alkaloid according to an embodiment of the present invention can increase the absorption rate and efficacy of the material by making the functional material for poor water solubility in water, so that the functionality of the material can be utilized in various fields.
  • Example 2 is a photograph of the emulsified particles of the alkaloid-containing water-soluble emulsion composition of Example 1 observed under an optical microscope.
  • An alkaloid-containing water-soluble emulsion composition includes a water-soluble antioxidant emulsion and an alkaloid emulsion.
  • the water-soluble antioxidant emulsion is 1 to 40% by weight of tocopherol, 1 to 40% by weight of catechin, 1 to 30% by weight of the first surfactant of HLB 3 to HLB 7, HLB 10 to HLB 14 to satisfy 100% by weight of the total amount of the water-soluble antioxidant emulsion 10 to 80% by weight of a second surfactant, 10 to 45% by weight of a cosurfactant, and 1 to 35% by weight of an edible oil and fat.
  • the tocopherol and catechin are included in the emulsion as fat-soluble and water-soluble antioxidants, respectively, and the content may be appropriately determined within the range of 1 to 40 wt%. For example, it may be 5 to 35% by weight, 5 to 25% by weight, 5 to 10% by weight, but is not limited thereto. At this time, if the content of tocopherol and catechin is less than the above range, the antioxidant effect of the addition is insignificant. On the contrary, if it exceeds the above range, there is a problem that the emulsion stability of the emulsion is significantly reduced.
  • the HLB Hydrophilicity
  • the water-soluble antioxidant emulsion and the alkaloid emulsion include two surfactants with different HLB (Hydrophile-Lipophile Balance) in terms of securing the emulsion stability of each emulsion, and exhibiting the surfactant effect while being well soluble in the hydrophilic co-surfactant. do.
  • HLB Hydrophilic co-surfactant
  • the first surfactant uses a HLB of 3 to 7
  • the second surfactant uses a HLB of 10 to 14 to prevent aggregation between emulsified particles, and is an antioxidant in the hydrophilic co-surfactant and edible oil Tocopherol and catechin are more effective in terms of maintaining their respective antioxidant powers.
  • HLB of the first surfactant is less than 3
  • the emulsion is not well formed, and when the HLB exceeds 7, agglomeration between particles occurs and the emulsion stability is reduced.
  • the HLB of the second surfactant is less than 10, it is difficult to emulsify, and on the contrary, when the HLB exceeds 14, the emulsion stability is deteriorated.
  • the first surfactant of HLB 3 to HLB 7 may be used without limitation as long as it is known, for example, from the group consisting of glycerin fatty acid ester, polyglycerol fatty acid ester, sorbitan fatty ester, lecithin, propylene glycol fatty acid ester, and mixtures thereof. Only 1 selected type is possible.
  • the content of the first surfactant is 1 to 30% by weight based on the total weight of the water-soluble antioxidant emulsion. In one example, it may be selected from 5 to 20% by weight, 5 to 25% by weight, and 5 to 15% by weight. If the content of the first surfactant is less than the above range, the emulsification action on the emulsified particles of the edible oil is weakened, making it difficult to form an emulsion.
  • the second surfactant of HLB 10 to HLB 14 may be one selected from the group consisting of polyglycerin fatty acid ester, polyoxyethylene sorbitan fatty acid ester, sucrose fatty acid ester, enzymatically decomposed lecithin, and mixtures thereof, but is limited thereto not.
  • the content of the second surfactant may be appropriately determined in the range of 10 to 80% by weight based on the total weight of the water-soluble antioxidant emulsion, for example, 20 to 70% by weight, 30 to 60% by weight, 40 to 50% by weight.
  • the present invention is not limited thereto.
  • the tocopherol and catechin can be stably dispersed in the water-soluble antioxidant emulsion without impairing the antioxidant ability of tocopherol and catechin.
  • the co-surfactant serves as an auxiliary agent for emulsification and is used as a solubilizer.
  • the co-surfactant may be one selected from the group consisting of glycerin, sorbitol, polyethylene glycol, propylene glycol, triacetin, and mixtures thereof, but is not limited thereto.
  • the content of the co-surfactant is preferably 10 to 45% by weight based on the total weight of the water-soluble antioxidant emulsion. In one example, it may be selected from 10 to 40% by weight, 15 to 30% by weight, and 15 to 20% by weight. If the co-surfactant content is less than the above range, it is not easy to dissolve the catechin, and when used in excess of the above range, there is a problem in that emulsified particles are not well formed and emulsion stability is lowered.
  • the edible oil can be used without limitation as long as it is manufactured or processed using crude oil obtained from plants or animals or the raw material thereof.
  • at least one oil selected from soybean oil, corn oil, rapeseed oil, high oleic rapeseed oil, safflower oil, rice bran oil, palm oil, olive oil, sunflower oil, palm oil, wheat germ oil, and medium chain triglyceride (MCT Oil) is possible.
  • the content of such edible oils and fats may be 1 to 35% by weight based on the total weight of the composition, for example, 1 to 30% by weight, 3 to 25% by weight, 5 to 20% by weight, but is not limited thereto. If it is less than the above range, the amount of oil is too small to dissolve the tocopherol, and if it exceeds the above range, the stability over time of the emulsion is poor.
  • the alkaloid emulsion contains 1 to 30% by weight of alkaloids, 1 to 10% by weight of water-in-oil surfactants of HLB 3 to HLB 7, and 1 to 20 oil-in-water surfactants of HLB 10 to HLB 14 to satisfy 100% by weight of the total. % by weight, and 40 to 97% by weight of a cosurfactant.
  • the alkaloid may be used without limitation if it has a biological effect on a mammal when administered orally.
  • a biological effect on a mammal when administered orally.
  • piperine for example, piperine, capsaicin.
  • alkaloids are included in an amount of 1 to 30% by weight based on the total weight of the alkaloid emulsion. For example, it may be 1 to 30% by weight, 3 to 25% by weight, 5 to 20% by weight, 10 to 20% by weight, but is not limited thereto. If the content of the alkaloid is less than the above range, the effect of the addition is insignificant, and if it exceeds the above range, there is a problem in that it is difficult to form emulsified particles.
  • the alkaloid emulsion comprises a first surfactant and a second surfactant having the above-described HLB value in order to maintain the emulsion stability of the emulsion composition by exhibiting a surfactant effect while being well soluble in the hydrophilic co-surfactant.
  • the first surfactant having an HLB of 3 to 7 is included in an amount of 1 to 10% by weight based on the total weight of the alkaloid emulsion. In one example, it may be selected from 3 to 10 wt%, 5 to 10 wt%, and 8 to 10 wt%. If the content of the first surfactant is less than the above range, there is a problem in that it is difficult to form an emulsion because the emulsification action on the alkaloid emulsified particles is weakened.
  • the second surfactant having an HLB of 10 to 14 may be contained in an amount of 1 to 20% by weight based on the total weight of the alkaloid emulsion, for example, 3 to 20% by weight, 5 to 20% by weight, 10 to 20% by weight, However, the present invention is not limited thereto. At this time, if the content of the second surfactant is less than the above range, the emulsification action on the hydrophilic co-surfactant is weakened, making it difficult to emulsify, and if it exceeds the above range, there is a problem in that it is difficult to maintain emulsion stability.
  • first surfactant and the second surfactant are as described above.
  • the cosurfactant is added to disperse and dissolve the alkaloid and to play an auxiliary role in emulsification, and the content of the alkaloid emulsion is 40 to 97 wt%.
  • the content of the alkaloid emulsion is 40 to 97 wt%.
  • it may be 40 to 90% by weight, 40 to 80% by weight, 40 to 70% by weight, 50 to 60% by weight, but is not limited thereto. If it is less than the above range, it is difficult to maintain emulsion stability, and if it exceeds the above range, it is difficult to stably disperse the alkaloid.
  • the alkaloid-containing water-soluble emulsion composition comprises 0.1 to 20% by weight of the water-soluble antioxidant emulsion; and 80 to 99.9 wt% of the alkaloid emulsion.
  • the water-soluble antioxidant emulsion may be 0.1 to 15% by weight, 0.1 to 10% by weight, 1 to 15% by weight, 1 to 10% by weight, but is not limited thereto.
  • the alkaloid emulsion may be 80 to 99.9 wt%, 80 to 99.9 wt%, 90 to 99.9 wt%, 90 to 99 wt%, but is not limited thereto.
  • the water-soluble emulsion composition containing alkaloids of the present invention can increase the absorption rate and efficacy of substances by soluble in alkaloids, which are functional substances for poor water use, so that the functional properties of substances can be utilized in various fields.
  • it since it contains a water-soluble antioxidant emulsion, it has excellent oxidation stability that can prevent oxidation by oxygen in aqueous solution.
  • raw material 1 was prepared by sequentially adding catechin, soybean oil, and tocopherol.
  • raw material 2 was prepared by adding a second surfactant to glycerin.
  • the second surfactant 30 wt% and 70 wt% of the total amount of the raw material 1 and 2 were used, respectively.
  • Preparation 9 Preparation 10
  • Preparation 11 Preparation 12
  • Preparation 13 Preparation 14 piperine 20.0 20.0 20.0 20.0 20.0 20.0 20.0 20.0 first surfactant glycerin fatty acid esters (HLB:4) 10.0 - 10.0 - - 30.0 sucrose fatty acid esters (HLB: 2) - 10.0 - - - - Polyglyceryl-6 diisostearate (HLB: 8) - 10.0 - second surfactant polyglycerin fatty acid esters (HLB: 12) 20.0 20.0 - - 30.0 - Polyglyceryl-6 diisostearate (HLB: 8) - - 20.0 - - - PEG-18 Stearate (HLB: 18) - - - - 20.0 - - glycerin 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0
  • Preparation 15 Ingredients/mixture ratio (wt%) Preparation 15
  • Preparation 16 Preparation 17
  • Preparation 18 Preparation 19
  • Preparation 20 capsaicin 20.0 20.0 20.0 20.0 20.0 20.0 20.0 20.0 first surfactant glycerin fatty acid esters (HLB:4) 10.0 - 10.0 - - 30.0 sucrose fatty acid esters (HLB: 2) - 10.0 - - - - - Polyglyceryl-6 diisostearate (HLB: 8) - 10.0 - second surfactant polyglycerin fatty acid esters (HLB: 12) 20.0 20.0 - - 30.0 - Polyglyceryl-6 diisostearate (HLB: 8) - - 20.0 - - - PEG-18 Stearate (HLB: 18) - - - - 20.0 - - glycerin 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0
  • the mixture was stirred at 500 rpm or less while maintaining the temperature at 50° C. or higher.
  • the homomixer was stirred and the rpm was gradually increased while emulsifying and dispersing at 5,000 rpm or higher.
  • glycerin was added and stirred at 500 rpm or less to prepare an alkaloid emulsion.
  • the antioxidant effect of the alkaloid-containing water-soluble emulsion composition including the water-soluble antioxidant emulsion was measured using the DPPH measurement method.
  • Measurement of DPPH radical scavenging activity is the most commonly used method to measure antioxidant activity, and it is a method to evaluate antioxidant activity by color change. Since many changes do not occur, the absorbance is measured with a spectrophotometer (517 nm) to compare the antioxidant activity, and the higher the value, the higher the antioxidant effect is evaluated.
  • Experimental conditions severe condition test: oxidation induced by leaving at 40°C for 1 week) are as follows.
  • the aqueous solubility of the prepared alkaloid-containing water-soluble emulsion composition was confirmed as follows. 50 ml of distilled water was added to the emulsion composition of Examples and Comparative Examples while maintaining a water temperature of 38° C. in a constant temperature water bath and maintaining a speed of 100 rpm. After 1 hour, centrifugation was followed by filtration, and the water content was measured by Karl Fisher method to quantify the organic matter content.
  • the emulsified particle size of the alkaloid-containing water-soluble emulsion composition prepared according to Tables 8 and 11 was confirmed as follows. 50 ml of distilled water was added to the emulsion composition of Examples and Comparative Examples while maintaining a water temperature of 38° C. in a constant temperature water bath and maintaining a speed of 100 rpm. After 1 hour, the emulsified particles were observed under an optical microscope, and the results are shown in FIGS. 1 and 2 .
  • the size of the emulsified particles in the distilled water was measured using a Zetasizer Nano ZS (Malvern Instrument, U.K.). At this time, the sample was repeatedly measured three times, and the average value is shown in Table 15 below.
  • the alkaloid-containing water-soluble emulsion composition according to an embodiment of the present invention forms emulsified particles of 1.0 to 5.0 ⁇ m, while the alkaloid-containing water-soluble emulsion composition of Comparative Examples 33 to 52 The composition did not form emulsified particles, so the size of the emulsified particles could not be measured. From this, it can be expected that the alkaloid-containing water-soluble emulsion composition according to the present invention can be absorbed in the body and exhibit high bioavailability.

Abstract

The present invention relates to an alkaloid-containing, water-soluble emulsified composition including a water-soluble antioxidant emulsion. An alkaloid-containing, water-soluble emulsified composition according to an embodiment of the present invention can solubilize a water-insoluble, functional material in water to increase the absorption rate and efficacy of the material, thus making it possible to utilize the functionality of the material in various fields. In addition, containing a water-soluble antioxidant emulsion, the composition is superb in terms of oxidation stability, which accounts for ability to prevent oxygen-induced oxidation in an aqueous solution.

Description

알칼로이드 함유 수용성 유화 조성물Alkaloid-containing water-soluble emulsion composition
본 발명은 수용성 항산화제 유화물을 함유하는 알칼로이드 함유 수용성 유화 조성물에 관한 것이다. The present invention relates to an alkaloid-containing water-soluble emulsion composition containing a water-soluble antioxidant emulsion.
알칼로이드(alkaloids)는 질소를 포함하고 있는 염기성 화합물로써 비교적 소량으로 사람과 동물에 강한 약리작용을 나타내는 유기 화합물의 총칭이며, 사람과 동물에게 특이적이고 강한 생리작용을 주는 특성이 있어 의약품으로 주로 이용된다.Alkaloids are basic compounds containing nitrogen, and are a generic term for organic compounds that exhibit strong pharmacological effects on humans and animals in relatively small amounts. .
알칼로이드를 다량 함유한 식물은 대부분 약초로 알려져 있으며 주로 열대 또는 아열대 식물이 많고 이러한 알칼로이드에는 약리작용과 함께 독성작용도 있어 상용하면 중독증상을 일으킬 수 있으므로, 의약품이 아닌 자연적으로 존재하는 알칼로이드 고 함유 식품을 섭취할 때는 주의가 필요하다. Most of the plants containing a large amount of alkaloids are known as medicinal herbs, and there are mainly tropical or subtropical plants. These alkaloids also have pharmacological and toxic effects. Caution is required when consuming.
이와 같은 알칼로이드를 비롯한 기능성 천연물들은 대부분 수난용성이며 체내흡수성이 매우 낮아 생체 이용률이 떨어지는 문제점이 있다. 따라서 이들이 갖는 생리활성물질을 활용한 식품, 의약품, 사료 등의 적용에 제한점이 있다. 또한 기존의 수용화된 기능성 유화물들은 O/W형의 유화물로 수상인 물과 물에 함유되어 산소에 의해서 산화되어 항산화 효능을 소실하거나 산패되는 문제점을 가지고 있다. Most of these functional natural products, including alkaloids, are poorly soluble in water and have very low bioavailability due to their very low bioavailability. Therefore, there is a limit to the application of food, medicine, feed, etc. utilizing their physiologically active substances. In addition, existing water-soluble functional emulsions are O/W-type emulsions, which are contained in water and water, which are aqueous phases, and are oxidized by oxygen to lose antioxidant efficacy or to go rancid.
한편, α-Tocopherol은 대표적인 천연 항산화제로써 종자유(Seed oil)나 곡류 그리고 녹색 잎을 갖는 야채에 많이 분포되어 있으며, 비타민 E로써 세포막에 존재하는 주요한 지용성의 항산화제이며, 지방의 산화를 막아준다. 비타민 E는 퍼옥시 라디칼(ROO·), CCl3, HO· 포함하는 다양한 산소 라디칼뿐만 아니라 수퍼옥사이드 라디칼(O2·)과 직접 반응할 수 있다. 항산화력은 δ > γ > β> α 순으로 높다. 작용기작으로 세포막을 구성하는 다가불포화지방산은 세포에서 만들어진 자유라디칼에 의해 쉽게 산화되는데, 토코페롤은 이러한 산화과정을 중단시키고 자유라디칼을 제거해 세포막을 산화적 손상으로부터 보호해준다. On the other hand, α-Tocopherol is a representative natural antioxidant, widely distributed in seed oil, grains, and vegetables with green leaves. As vitamin E, it is a major fat-soluble antioxidant present in cell membranes and prevents oxidation of fat. . Vitamin E can react directly with various oxygen radicals including peroxy radicals (ROO·), CCl 3 , HO· as well as superoxide radicals (O 2 ·). The antioxidant activity is high in the order of δ > γ > β > α. As a mechanism of action, polyunsaturated fatty acids composing cell membranes are easily oxidized by free radicals made in cells. Tocopherol stops this oxidation process and removes free radicals to protect cell membranes from oxidative damage.
본 발명의 과제는 기능성 난용성 물질을 수용화 시켜 물질의 흡수율과 효능을 증대시킬 수 있을 뿐만 아니라 수용액 상에서 산화 안정성이 우수한 알칼로이드 함유 수용성 유화 조성물을 제공하는 것이다. An object of the present invention is to provide an alkaloid-containing water-soluble emulsion composition that not only can water-soluble functionally poorly soluble substances to increase the absorption rate and efficacy of the substances, but also has excellent oxidative stability in aqueous solution.
상기한 과제를 달성하기 위해 본 발명은 In order to achieve the above object, the present invention
(1) 전체 100 중량%를 만족하도록 하기 성분을 포함하는 수용성 항산화제 유화물: (1) A water-soluble antioxidant emulsion comprising the following ingredients to satisfy 100% by weight of the total:
토코페롤 1 내지 40 중량%,1 to 40% by weight of tocopherol,
카테킨 1 내지 40 중량%,1 to 40% by weight of catechin,
HLB 3 내지 HLB 7의 제1 계면활성제 1 내지 30 중량%,1 to 30% by weight of a first surfactant of HLB 3 to HLB 7,
HLB 10 내지 HLB 14의 제2 계면활성제 10 내지 80 중량%;10 to 80% by weight of a second surfactant of HLB 10 to HLB 14;
공계면활성제 10 내지 45 중량%, 및10 to 45% by weight of a cosurfactant, and
식용 유지 1 내지 35 중량%,1 to 35% by weight of edible oil,
(2) 전체 100 중량%를 만족하도록 하기 성분을 포함하는 알칼로이드 유화물:(2) an alkaloid emulsion comprising the following components to satisfy the total 100% by weight:
알칼로이드 1 내지 30 중량%,1 to 30% by weight of an alkaloid;
HLB 3 내지 HLB 7의 제1 계면활성제 1 내지 10 중량%,1 to 10% by weight of a first surfactant of HLB 3 to HLB 7,
HLB 10 내지 HLB 14의 제2 계면활성제 1 내지 20 중량%, 및1 to 20% by weight of a second surfactant of HLB 10 to HLB 14, and
공계면활성제 40 내지 97 중량%, 40 to 97% by weight of co-surfactant,
를 포함하는, 수용성 항산화제 유화물을 함유하는 알칼로이드 함유 수용성 유화 조성물을 제공한다. It provides an alkaloid-containing water-soluble emulsion composition containing a water-soluble antioxidant emulsion comprising a.
본 발명의 일 구현예에 따른 알칼로이드 함유 수용성 유화 조성물은 기능성 수난용 물질을 수용화 시킴으로써 물질의 흡수율과 효능을 증대시킬 수 있어, 물질이 갖는 기능성을 다양한 분야에 활용될 수 있도록 한다.The water-soluble emulsion composition containing an alkaloid according to an embodiment of the present invention can increase the absorption rate and efficacy of the material by making the functional material for poor water solubility in water, so that the functionality of the material can be utilized in various fields.
또한, 수용성 항산화제 유화물을 함유하여, 수용액 상에서 산소에 의한 산화를 예방할 수 있는 산화 안정성이 우수하다. In addition, since it contains a water-soluble antioxidant emulsion, it has excellent oxidation stability that can prevent oxidation by oxygen in aqueous solution.
도 1은 비교예 33의 알칼로이드 함유 수용성 유화 조성물의 유화 입자를 광학현미경으로 관찰한 사진이다. 1 is a photograph of observation of emulsified particles of an alkaloid-containing water-soluble emulsion composition of Comparative Example 33 under an optical microscope.
도 2는 실시예 1의 알칼로이드 함유 수용성 유화 조성물의 유화 입자를 광학현미경으로 관찰한 사진이다. 2 is a photograph of the emulsified particles of the alkaloid-containing water-soluble emulsion composition of Example 1 observed under an optical microscope.
이하 본 발명의 일 구현예에 따른 수용성 항산화 유화물과 알칼로이드 유화물을 상세히 설명한다. Hereinafter, a water-soluble antioxidant emulsion and an alkaloid emulsion according to an embodiment of the present invention will be described in detail.
본 발명의 일 구현예에 따른 알칼로이드 함유 수용성 유화 조성물은 수용성 항산화 유화물과 알칼로이드 유화물을 포함한다. An alkaloid-containing water-soluble emulsion composition according to an embodiment of the present invention includes a water-soluble antioxidant emulsion and an alkaloid emulsion.
상기 수용성 항산화제 유화물은 전체 100 중량%를 만족하도록, 토코페롤 1 내지 40 중량%, 카테킨 1 내지 40 중량%, HLB 3 내지 HLB 7의 제1 계면활성제 1 내지 30 중량%, HLB 10 내지 HLB 14의 제2 계면활성제 10 내지 80 중량%, 공계면활성제 10 내지 45 중량%, 및 식용 유지 1 내지 35 중량%를 포함한다. The water-soluble antioxidant emulsion is 1 to 40% by weight of tocopherol, 1 to 40% by weight of catechin, 1 to 30% by weight of the first surfactant of HLB 3 to HLB 7, HLB 10 to HLB 14 to satisfy 100% by weight of the total amount of the water-soluble antioxidant emulsion 10 to 80% by weight of a second surfactant, 10 to 45% by weight of a cosurfactant, and 1 to 35% by weight of an edible oil and fat.
상기 토코페롤과 카테킨은 각각 지용성, 수용성 항산화제로서 유화물 내에 포함되며, 그 함량은 1 내지 40 중량% 범위 내에서 적절하게 정할 수 있다. 예컨대, 5 내지 35 중량%, 5 내지 25 중량%, 5 내지 10 중량%일 수 있으나, 이에 제한되는 것은 아니다. 이때 토코페롤과 카테킨의 함량이 상기 범위 미만이면 첨가에 따른 항산화 효과가 미미하고, 이와 반대로 상기 범위를 초과하면 유화물의 유화 안정성이 현저히 저하되는 문제점이 있다. The tocopherol and catechin are included in the emulsion as fat-soluble and water-soluble antioxidants, respectively, and the content may be appropriately determined within the range of 1 to 40 wt%. For example, it may be 5 to 35% by weight, 5 to 25% by weight, 5 to 10% by weight, but is not limited thereto. At this time, if the content of tocopherol and catechin is less than the above range, the antioxidant effect of the addition is insignificant. On the contrary, if it exceeds the above range, there is a problem that the emulsion stability of the emulsion is significantly reduced.
상기 HLB(Hydrophile-Lipophile Balance)는 계면활성제가 물과 기름에 대한 친화성 정도를 나타내는 값이며, HLB는 그 값이 작을수록 분자 전체로서 친유성이 강하고, 그 값이 커질수록 친수성이 강한 것을 나타낸다. The HLB (Hydrophile-Lipophile Balance) is a value indicating the affinity of the surfactant to water and oil, and HLB indicates that the smaller the value, the stronger the lipophilicity of the molecule as a whole, and the larger the value, the stronger the hydrophilicity. .
상기 수용성 항산화 유화물과 알칼로이드 유화물은 각 유화물의 유화 안정성을 확보하고, 친수성 공계면활성제 내에 잘 녹으면서 계면활성 효과를 나타내기 위한 측면에서 HLB(Hydrophile-Lipophile Balance)가 상이한 2종의 계면활성제를 포함한다. The water-soluble antioxidant emulsion and the alkaloid emulsion include two surfactants with different HLB (Hydrophile-Lipophile Balance) in terms of securing the emulsion stability of each emulsion, and exhibiting the surfactant effect while being well soluble in the hydrophilic co-surfactant. do.
상기 제1 계면활성제는 HLB가 3 내지 7인 것을 사용하고, 제2 계면활성제는 HLB가 10 내지 14인 것을 사용하는 것이 유화 입자 간 응집을 방지하고, 친수성 공계면활성제와 식용 유지 내에서 항산화제인 토코페롤과 카테킨이 각각의 항산화력을 유지하기 위한 측면에서 더욱 효과적이다. 상기 제1 계면활성제의 HLB가 3 미만인 경우 에멀젼이 잘 형성되지 않으며, HLB가 7을 초과하는 경우 입자 간 응집이 발생하여 유화 안정성이 저하된다. 상기 제2 계면활성제의 HLB가 10 미만인 경우 유화가 어렵고, 반대로 HLB 14를 초과하는 경우 유화 안정성이 떨어진다. The first surfactant uses a HLB of 3 to 7, and the second surfactant uses a HLB of 10 to 14 to prevent aggregation between emulsified particles, and is an antioxidant in the hydrophilic co-surfactant and edible oil Tocopherol and catechin are more effective in terms of maintaining their respective antioxidant powers. When the HLB of the first surfactant is less than 3, the emulsion is not well formed, and when the HLB exceeds 7, agglomeration between particles occurs and the emulsion stability is reduced. When the HLB of the second surfactant is less than 10, it is difficult to emulsify, and on the contrary, when the HLB exceeds 14, the emulsion stability is deteriorated.
상기 HLB 3 내지 HLB 7의 제1 계면활성제는 공지된 것이라면 제한 없이 사용할 수 있으며, 예컨대 글리세린 지방산 에스테르, 폴리글리세린 지방산 에스테르, 솔비탄 지방 에스테르, 레시틴, 프로필렌글리콜 지방산 에스테르 및 이들의 혼합물로 이루어진 군에서 선택된 1종이 가능하다. 이때 제1 계면활성제의 함량은 수용성 항산화제 유화물 전체 중량에 대해 1 내지 30 중량%이다. 일 예에서, 5 내지 20 중량%, 5 내지 25 중량%, 5 내지 15 중량%에서 선택될 수 있다. 제1 계면활성제의 함량이 상기 범위 미만이면 식용 유지의 유화 입자에 대한 유화 작용이 약화되어 에멀젼 형성이 어렵고, 상기 범위를 초과하면 유화 안정성이 떨어지는 문제점이 있다. The first surfactant of HLB 3 to HLB 7 may be used without limitation as long as it is known, for example, from the group consisting of glycerin fatty acid ester, polyglycerol fatty acid ester, sorbitan fatty ester, lecithin, propylene glycol fatty acid ester, and mixtures thereof. Only 1 selected type is possible. At this time, the content of the first surfactant is 1 to 30% by weight based on the total weight of the water-soluble antioxidant emulsion. In one example, it may be selected from 5 to 20% by weight, 5 to 25% by weight, and 5 to 15% by weight. If the content of the first surfactant is less than the above range, the emulsification action on the emulsified particles of the edible oil is weakened, making it difficult to form an emulsion.
상기 HLB 10 내지 HLB 14의 제2 계면활성제는 폴리글리세린 지방산 에스테르, 폴리옥시에틸렌 솔비탄 지방산 에스테르, 자당 지방산 에스테르, 효소분해 레시틴 및 이들의 혼합물로 이루어진 군에서 선택된 1종이 가능하나, 이에 한정되는 것은 아니다. 이때 제2 계면활성제의 함량은 수용성 항산화제 유화물 전체 중량에 대해 10 내지 80 중량% 범위에서 적절하게 정할 수 있으며, 예컨대, 20 내지 70 중량%, 30 내지 60 중량%, 40 내지 50 중량%일 수 있으나, 이에 제한되는 것은 아니다. 상기 제2 계면활성제의 함량이 상기 수치 범위를 만족하는 경우, 토코페롤과 카테킨의 항산화능을 해하지 않으면서, 수용성 항산화제 유화물 내에 토코페롤과 카테킨이 안정적으로 분산될 수 있도록 한다. The second surfactant of HLB 10 to HLB 14 may be one selected from the group consisting of polyglycerin fatty acid ester, polyoxyethylene sorbitan fatty acid ester, sucrose fatty acid ester, enzymatically decomposed lecithin, and mixtures thereof, but is limited thereto not. At this time, the content of the second surfactant may be appropriately determined in the range of 10 to 80% by weight based on the total weight of the water-soluble antioxidant emulsion, for example, 20 to 70% by weight, 30 to 60% by weight, 40 to 50% by weight. However, the present invention is not limited thereto. When the content of the second surfactant satisfies the above numerical range, the tocopherol and catechin can be stably dispersed in the water-soluble antioxidant emulsion without impairing the antioxidant ability of tocopherol and catechin.
상기 공계면활성제는 유화에 보조적인 역할을 할 뿐만 아니라 용해제로 사용된다. 상기 공계면활성제는 글리세린, 솔비톨, 폴리에틸렌글리콜, 프로필렌글리콜, 트리아세틴 및 이들의 혼합물로 이루어진 군에서 선택된 1종이 가능하나, 이에 한정되는 것은 아니다. 이러한 공계면활성제의 함량은 수용성 항산화제 유화물 총 중량 대비 10 내지 45 중량%인 것이 바람직하다. 일 예에서, 10 내지 40 중량%, 15 내지 30 중량%, 15 내지 20 중량% 범위에서 선택될 수 있다. 공계면활성제 함량이 상기 범위 미만이면 카테킨을 용해시키는 것이 용이하지 않으며, 상기 범위를 초과하여 사용하면 유화 입자가 잘 형성되지 않고 유화 안정성이 저하되는 문제가 있다. The co-surfactant serves as an auxiliary agent for emulsification and is used as a solubilizer. The co-surfactant may be one selected from the group consisting of glycerin, sorbitol, polyethylene glycol, propylene glycol, triacetin, and mixtures thereof, but is not limited thereto. The content of the co-surfactant is preferably 10 to 45% by weight based on the total weight of the water-soluble antioxidant emulsion. In one example, it may be selected from 10 to 40% by weight, 15 to 30% by weight, and 15 to 20% by weight. If the co-surfactant content is less than the above range, it is not easy to dissolve the catechin, and when used in excess of the above range, there is a problem in that emulsified particles are not well formed and emulsion stability is lowered.
상기 식용 유지는 식물 또는 동물로부터 얻은 원유나 이를 원료로 하여 제조, 가공한 것이라면 제한 없이 사용 가능하다. 예컨대, 대두유, 옥수수유, 채종유, 고올레산 채종유, 홍화유, 미강유, 팜유, 올리브유, 해바라기유, 야자유, 소맥 배아유, 중쇄중성지방(MCT Oil)에서 선택된 1종 이상의 유지가 가능하다. 이러한 식용 유지의 함량은 조성물 총 중량에 대해 1 내지 35 중량%일 수 있으며, 예컨대, 1 내지 30 중량%, 3 내지 25 중량%, 5 내지 20 중량%일 수 있으나, 이에 제한되는 것은 아니다. 상기 범위 미만에서는 오일의 양이 너무 적어 토코페롤의 용해가 어렵고, 상기 범위를 초과하면 에멀젼의 경시 안정성이 불량하다. The edible oil can be used without limitation as long as it is manufactured or processed using crude oil obtained from plants or animals or the raw material thereof. For example, at least one oil selected from soybean oil, corn oil, rapeseed oil, high oleic rapeseed oil, safflower oil, rice bran oil, palm oil, olive oil, sunflower oil, palm oil, wheat germ oil, and medium chain triglyceride (MCT Oil) is possible. The content of such edible oils and fats may be 1 to 35% by weight based on the total weight of the composition, for example, 1 to 30% by weight, 3 to 25% by weight, 5 to 20% by weight, but is not limited thereto. If it is less than the above range, the amount of oil is too small to dissolve the tocopherol, and if it exceeds the above range, the stability over time of the emulsion is poor.
상기 알칼로이드 유화물은 전체 100 중량%를 만족하도록, 알칼로이드 1 내지 30 중량%, HLB 3 내지 HLB 7의 유중 수적형 계면활성제 1 내지 10 중량%, HLB 10 내지 HLB 14의 수중 유적형 계면활성제 1 내지 20 중량%, 및 공계면활성제 40 내지 97 중량%를 포함한다. The alkaloid emulsion contains 1 to 30% by weight of alkaloids, 1 to 10% by weight of water-in-oil surfactants of HLB 3 to HLB 7, and 1 to 20 oil-in-water surfactants of HLB 10 to HLB 14 to satisfy 100% by weight of the total. % by weight, and 40 to 97% by weight of a cosurfactant.
상기 알칼로이드는 경구 투여시 포유동물에서 생물학적인 영향을 미치는 것은 제한 없이 사용할 수 있다. 일 예로, 피페린, 캡사이신이다. The alkaloid may be used without limitation if it has a biological effect on a mammal when administered orally. For example, piperine, capsaicin.
이러한 알칼로이드는 알칼로이드 유화물 전체 중량에 대해 1 내지 30 중량%로 포함된다. 예컨대, 1 내지 30 중량%, 3 내지 25 중량%, 5 내지 20 중량%, 10 내지 20 중량%일 수 있으나, 이에 제한되는 것은 아니다. 만약 알칼로이드의 함량이 상기 범위 미만이면 첨가에 따른 효과가 미미하고, 상기 범위를 초과하면 유화 입자 형성이 어려운 문제점이 있다. These alkaloids are included in an amount of 1 to 30% by weight based on the total weight of the alkaloid emulsion. For example, it may be 1 to 30% by weight, 3 to 25% by weight, 5 to 20% by weight, 10 to 20% by weight, but is not limited thereto. If the content of the alkaloid is less than the above range, the effect of the addition is insignificant, and if it exceeds the above range, there is a problem in that it is difficult to form emulsified particles.
알칼로이드 유화물은 친수성 공계면활성제 내에 잘 녹으면서 계면활성 효과를 나타내어 유화 조성물의 유화 안정성을 유지하기 위해 상기한 HLB 값을 갖는 제1 계면활성제와 제2 계면활성제를 포함한다.The alkaloid emulsion comprises a first surfactant and a second surfactant having the above-described HLB value in order to maintain the emulsion stability of the emulsion composition by exhibiting a surfactant effect while being well soluble in the hydrophilic co-surfactant.
HLB가 3 내지 7인 제1 계면활성제는 알칼로이드 유화물 전체 중량에 대해 1 내지 10 중량%로 포함된다. 일 예에서, 3 내지 10 중량%, 5 내지 10 중량%, 8 내지 10 중량% 범위에서 선택될 수 있다. 제1 계면활성제의 함량이 상기 범위 미만이면 알칼로이드 유화 입자에 대한 유화 작용이 약화되어 에멀젼 형성이 어려운 문제점이 있고, 상기 범위를 초과하면 유화 안정성이 저하되는 문제점이 있다. The first surfactant having an HLB of 3 to 7 is included in an amount of 1 to 10% by weight based on the total weight of the alkaloid emulsion. In one example, it may be selected from 3 to 10 wt%, 5 to 10 wt%, and 8 to 10 wt%. If the content of the first surfactant is less than the above range, there is a problem in that it is difficult to form an emulsion because the emulsification action on the alkaloid emulsified particles is weakened.
HLB가 10 내지 14인 제2 계면활성제는 알칼로이드 유화물 전체 중량에 대해 1 내지 20 중량%로 함유될 수 있으며, 예컨대 3 내지 20 중량%, 5 내지 20 중량%, 10 내지 20 중량%일 수 있으나, 이에 제한되는 것은 아니다. 이때 제2 계면활성제의 함량이 상기 범위 미만이면 친수성 공계면활성제에 대한 유화 작용이 약화되어 유화가 어렵고, 상기 범위를 초과하면 유화 안정성을 유지가 어려운 문제점이 있다. The second surfactant having an HLB of 10 to 14 may be contained in an amount of 1 to 20% by weight based on the total weight of the alkaloid emulsion, for example, 3 to 20% by weight, 5 to 20% by weight, 10 to 20% by weight, However, the present invention is not limited thereto. At this time, if the content of the second surfactant is less than the above range, the emulsification action on the hydrophilic co-surfactant is weakened, making it difficult to emulsify, and if it exceeds the above range, there is a problem in that it is difficult to maintain emulsion stability.
제1 계면활성제와 제2 계면활성제의 구체적인 종류는 상기에서 언급한 바를 따른다. Specific types of the first surfactant and the second surfactant are as described above.
상기 공계면활성제는 알칼로이드를 분산, 용해시키고, 유화에 보조적인 역할을 하기 위해 첨가되는 것으로, 알칼로이드 유화물 중 그 함량은 40 내지 97 중량%이다. 예컨대 40 내지 90 중량%, 40 내지 80 중량%, 40 내지 70 중량%, 50 내지 60 중량%일 수 있으나, 이에 제한되는 것은 아니다. 상기 범위 미만에서는 유화 안정성 유지가 어렵고, 상기 범위를 초과하면 알칼로이드의 안정적인 분산이 어렵다. The cosurfactant is added to disperse and dissolve the alkaloid and to play an auxiliary role in emulsification, and the content of the alkaloid emulsion is 40 to 97 wt%. For example, it may be 40 to 90% by weight, 40 to 80% by weight, 40 to 70% by weight, 50 to 60% by weight, but is not limited thereto. If it is less than the above range, it is difficult to maintain emulsion stability, and if it exceeds the above range, it is difficult to stably disperse the alkaloid.
상기 알칼로이드 함유 수용성 유화 조성물은 상기 수용성 항산화제 유화물 0.1 내지 20 중량%; 및 상기 알칼로이드 유화물 80 내지 99.9 중량%를 포함한다. 이때 상기 수용성 항산화제 유화물은 0.1 내지 15 중량%, 0.1 내지 10 중량%, 1 내지 15 중량%, 1 내지 10 중량%일 수 있으나, 이에 제한되는 것은 아니다. 또한 알칼로이드 유화물은 80 내지 99.9 중량%, 80 내지 99.9 중량%, 90 내지 99.9 중량%, 90 내지 99 중량%일 수 있으나, 이에 제한되는 것은 아니다.The alkaloid-containing water-soluble emulsion composition comprises 0.1 to 20% by weight of the water-soluble antioxidant emulsion; and 80 to 99.9 wt% of the alkaloid emulsion. At this time, the water-soluble antioxidant emulsion may be 0.1 to 15% by weight, 0.1 to 10% by weight, 1 to 15% by weight, 1 to 10% by weight, but is not limited thereto. In addition, the alkaloid emulsion may be 80 to 99.9 wt%, 80 to 99.9 wt%, 90 to 99.9 wt%, 90 to 99 wt%, but is not limited thereto.
본 발명의 알칼로이드 함유 수용성 유화 조성물은 기능성 수난용 물질인 알칼로이드를 수용화 시킴으로써 물질의 흡수율과 효능을 증대시킬 수 있어, 물질이 갖는 기능성을 다양한 분야에 활용될 수 있도록 한다. 또한, 수용성 항산화제 유화물을 함유하여, 수용액 상에서 산소에 의한 산화를 예방할 수 있는 산화 안정성이 우수하다. The water-soluble emulsion composition containing alkaloids of the present invention can increase the absorption rate and efficacy of substances by soluble in alkaloids, which are functional substances for poor water use, so that the functional properties of substances can be utilized in various fields. In addition, since it contains a water-soluble antioxidant emulsion, it has excellent oxidation stability that can prevent oxidation by oxygen in aqueous solution.
이하 본 발명을 실시예를 통해 상세히 설명한다. 그러나 이러한 실시예들로 본 발명의 범위를 한정하는 것은 아니다.Hereinafter, the present invention will be described in detail through examples. However, these examples do not limit the scope of the present invention.
실시예Example
하기 표 1 내지 표 9의 조성으로 각각 수용성 항산화제 유화물과 알칼로이드 유화물을 제조한 후 최종 알칼로이드 함유 수용성 유화 조성물을 제조하였다. After preparing a water-soluble antioxidant emulsion and an alkaloid emulsion, respectively, with the compositions shown in Tables 1 to 9 below, a final alkaloid-containing water-soluble emulsion composition was prepared.
성분/배합비(wt%)Ingredients/mixture ratio (wt%) 제조예 1Preparation Example 1 제조예 2Preparation 2 제조예 3Preparation 3 제조예 4Preparation 4 제조예 5Preparation 5 제조예 6Preparation 6 제조예 7Preparation 7 제조예 8Preparation 8
토코페롤tocopherol 10.010.0 10.010.0 15.015.0 -- 10.010.0 10.010.0 10.010.0 10.010.0
카테킨catechins 5.05.0 5.05.0 -- 15.015.0 5.05.0 5.05.0 5.05.0 5.05.0
제1계면활성제first surfactant 글리세린 지방산 에스테르
(HLB: 4)glycerin fatty acid esters
(HLB: 4) 		15.015.0 -- 15.015.0 15.015.0 15.015.0 -- -- 65.065.0
자당 지방산 에스테르
(HLB: 2)sucrose fatty acid esters
(HLB: 2) 		-- 15.015.0 -- -- -- -- -- --
폴리글리세릴-6 디이소스테아레이트
(HLB: 8)Polyglyceryl-6 diisostearate
(HLB: 8) 		15.015.0
제2계면활성제second surfactant 폴리글리세린 지방산 에스테르
(HLB:12)polyglycerin fatty acid esters
(HLB:12) 		50.050.0 50.050.0 50.050.0 50.050.0 -- -- 65.065.0 --
폴리글리세릴-6 디이소스테아레이트
(HLB: 8)Polyglyceryl-6 diisostearate
(HLB: 8) 		-- -- -- -- 50.050.0 -- -- --
PEG-18 스테아레이트
(HLB: 18)PEG-18 Stearate
(HLB: 18) 		-- -- -- -- -- 50.050.0 -- --
글리세린glycerin 15.015.0 15.015.0 15.015.0 15.015.0 15.015.0 15.015.0 15.015.0 15.015.0
대두유soybean oil 5.05.0 5.05.0 5.05.0 5.05.0 5.05.0 5.05.0 5.05.0 5.05.0
제1계면활성제, 제2계면활성제를 호모 믹서에 투입한 후, 온도를 50 ℃ 이상으로 유지하면서 500 rpm 이하로 교반하였다. 이후 카테킨, 대두유, 토코페롤을 순차적으로 투입하여 원료 1을 제조하였다. 이와는 별도로 글리세린에 제2계면활성제를 투입하여 원료 2를 제조하였다.After adding the first surfactant and the second surfactant to the homomixer, the mixture was stirred at 500 rpm or less while maintaining the temperature at 50° C. or higher. Thereafter, raw material 1 was prepared by sequentially adding catechin, soybean oil, and tocopherol. Separately, raw material 2 was prepared by adding a second surfactant to glycerin.
이때 제2계면활성제는 원료 1과 원료 2에 총 사용량 중 30 중량%와 70 중량%를 각각 사용하였다. In this case, as the second surfactant, 30 wt% and 70 wt% of the total amount of the raw material 1 and 2 were used, respectively.
원료 2에 원료 1을 혼합하면서 호모믹서로 5,000 rpm 이상으로 유화 분산을 진행하여 수용성 항산화제 유화물을 제조하였다. While mixing the raw material 1 with the raw material 2, emulsification and dispersion were carried out at 5,000 rpm or more with a homomixer to prepare a water-soluble antioxidant emulsion.
성분/배합비(wt%)Ingredients/mixture ratio (wt%) 제조예 9Preparation 9 제조예 10 Preparation 10 제조예 11Preparation 11 제조예 12Preparation 12 제조예 13Preparation 13 제조예 14Preparation 14
피페린piperine 20.020.0 20.020.0 20.020.0 20.020.0 20.020.0 20.020.0
제1계면활성제first surfactant 글리세린 지방산 에스테르
(HLB:4)glycerin fatty acid esters
(HLB:4) 		10.010.0 -- 10.010.0 -- -- 30.030.0
자당 지방산 에스테르
(HLB: 2)sucrose fatty acid esters
(HLB: 2) 		-- 10.010.0 -- -- -- --
폴리글리세릴-6 디이소스테아레이트
(HLB: 8)Polyglyceryl-6 diisostearate
(HLB: 8) 		-- 10.010.0 --
제2계면활성제second surfactant 폴리글리세린 지방산 에스테르
(HLB: 12)polyglycerin fatty acid esters
(HLB: 12) 		20.020.0 20.020.0 -- -- 30.030.0 --
폴리글리세릴-6 디이소스테아레이트
(HLB: 8)Polyglyceryl-6 diisostearate
(HLB: 8) 		-- -- 20.020.0 -- -- --
PEG-18 스테아레이트
(HLB: 18)PEG-18 Stearate
(HLB: 18) 		-- -- -- 20.020.0 -- --
글리세린glycerin 50.050.0 50.050.0 50.050.0 50.050.0 50.050.0 50.050.0
성분/배합비(wt%)Ingredients/mixture ratio (wt%) 제조예 15Preparation 15 제조예 16Preparation 16 제조예 17Preparation 17 제조예 18Preparation 18 제조예 19Preparation 19 제조예 20Preparation 20
캡사이신capsaicin 20.020.0 20.020.0 20.020.0 20.020.0 20.020.0 20.020.0
제1계면활성제first surfactant 글리세린 지방산 에스테르
(HLB:4)glycerin fatty acid esters
(HLB:4) 		10.010.0 -- 10.010.0 -- -- 30.030.0
자당 지방산 에스테르
(HLB: 2)sucrose fatty acid esters
(HLB: 2) 		-- 10.010.0 -- -- -- --
폴리글리세릴-6 디이소스테아레이트
(HLB: 8)Polyglyceryl-6 diisostearate
(HLB: 8) 		-- 10.010.0 --
제2계면활성제second surfactant 폴리글리세린 지방산 에스테르
(HLB: 12)polyglycerin fatty acid esters
(HLB: 12) 		20.020.0 20.020.0 -- -- 30.030.0 --
폴리글리세릴-6 디이소스테아레이트
(HLB: 8)Polyglyceryl-6 diisostearate
(HLB: 8) 		-- -- 20.020.0 -- -- --
PEG-18 스테아레이트
(HLB: 18)PEG-18 Stearate
(HLB: 18) 		-- -- -- 20.020.0 -- --
글리세린glycerin 50.050.0 50.050.0 50.050.0 50.050.0 50.050.0 50.050.0
제1계면활성제, 제2계면활성제를 호모 믹서에 투입한 후, 온도를 50℃ 이상으로 유지하면서 500 rpm 이하로 교반하였다. 이후 알칼로이드 원료를 투입하고 엑타이손이 유화물에 습윤되기 시작하면, 호모믹서의 교반을 시작하여 서서히 rpm을 올리면서 5,000 rpm 이상에서 유화 분산을 진행하였다. 유화가 완료되면 글리세린을 투입한 후 500 rpm 이하에서 교반하여 알칼로이드 유화물을 제조하였다.After adding the first surfactant and the second surfactant to the homomixer, the mixture was stirred at 500 rpm or less while maintaining the temperature at 50° C. or higher. After that, when the alkaloid raw material was added and the ectysone started to wet the emulsion, the homomixer was stirred and the rpm was gradually increased while emulsifying and dispersing at 5,000 rpm or higher. When the emulsification was completed, glycerin was added and stirred at 500 rpm or less to prepare an alkaloid emulsion.
구분
(중량%)division
(weight%) 		실시예 1Example 1 실시예 2Example 2 비교예 1Comparative Example 1 비교예 2Comparative Example 2 비교예 3Comparative Example 3 비교예 4Comparative Example 4
수용성 항산화제 유화물Water Soluble Antioxidant Emulsion 제조예 1
(1 중량%)Preparation Example 1
(1% by weight) 		제조예 1
( 10 중량%)Preparation Example 1
(10% by weight) 		제조예 3
(1 중량%)Preparation 3
(1% by weight) 		제조예 3
(10 중량%)Preparation 3
(10% by weight) 		제조예 4
(1 중량%)Preparation 4
(1% by weight) 		제조예 4
(10 중량%)Preparation 4
(10% by weight)
피페린 유화물piperine emulsion 제조예 9
(99 중량%)Preparation 9
(99% by weight) 		제조예 9
(90 중량%)Preparation 9
(90% by weight) 		제조예 9
(99 중량%)Preparation 9
(99% by weight) 		제조예 9
(90 중량%)Preparation 9
(90% by weight) 		제조예 9
(99 중량%)Preparation 9
(99% by weight) 		제조예 9
(90 중량%)Preparation 9
(90% by weight)
구분
(중량%)division
(weight%) 		실시예 3Example 3 실시예 4Example 4 비교예 5Comparative Example 5 비교예 6Comparative Example 6 비교예 7Comparative Example 7 비교예 8Comparative Example 8
수용성 항산화제 유화물Water Soluble Antioxidant Emulsion 제조예 1
(1 중량%)Preparation Example 1
(1% by weight) 		제조예 1
( 10 중량%)Preparation Example 1
(10% by weight) 		제조예 3
(1 중량%)Preparation 3
(1% by weight) 		제조예 3
(10 중량%)Preparation 3
(10% by weight) 		제조예 4
(1 중량%)Preparation 4
(1% by weight) 		제조예 4
(10 중량%)Preparation 4
(10% by weight)
캡사이신 유화물capsaicin emulsion 제조예 15
(99 중량%)Preparation 15
(99% by weight) 		제조예 15
(90 중량%)Preparation 15
(90% by weight) 		제조예 15
(99 중량%)Preparation 15
(99% by weight) 		제조예 15
(90 중량%)Preparation 15
(90% by weight) 		제조예 15
(99 중량%)Preparation 15
(99% by weight) 		제조예 15
(90 중량%)Preparation 15
(90% by weight)
상기 표 4 내지 표 5에 기재된 조성에 따라 이렇게 얻은 알칼로이드 유화물에 상기에서 제조된 수용성 항산화제 유화물을 투입한 후 유화액의 성상을 확인하면서 500 rpm 이하에서 혼합 분산 작업을 진행하여 수용성 항산화제 유화물을 함유하는 알칼로이드 함유 수용성 유화 조성물을 제조하였다. After adding the water-soluble antioxidant emulsion prepared above to the alkaloid emulsion thus obtained according to the composition shown in Tables 4 to 5, mixing and dispersing at 500 rpm or less while checking the properties of the emulsion to contain the water-soluble antioxidant emulsion An alkaloid-containing water-soluble emulsion composition was prepared.
실험예Experimental example 1: 항산화 효과 측정 1: Measurement of antioxidant effect
DPPH 측정법을 이용하여 수용성 항산화제 유화물을 포함하는 알칼로이드 함유 수용성 유화 조성물의 항산화 효과를 측정하였다. The antioxidant effect of the alkaloid-containing water-soluble emulsion composition including the water-soluble antioxidant emulsion was measured using the DPPH measurement method.
DPPH 라디칼 소거 활성 측정은 항산화능을 측정하는데 가장 보편적으로 사용되는 방법으로 색상 변화로 항산화능을 평가하는 방법으로, 항산화능이 뛰어난 시료를 처리하면 색의 변화가 뚜렷하고 효과가 떨어지는 시료를 처리하면 보라색에서 많은 변화가 일어나지 않아서 이러한 변화 정도를 spectrophotometer(517nm)로 흡광도를 측정하여 항산화능을 비교하며, 값이 높을수록 항산화 효과도 높다고 평가한다. 실험조건(가혹조건 시험: 40℃에서 1주일간 방치하여 산화 유도)은 아래와 같다. Measurement of DPPH radical scavenging activity is the most commonly used method to measure antioxidant activity, and it is a method to evaluate antioxidant activity by color change. Since many changes do not occur, the absorbance is measured with a spectrophotometer (517 nm) to compare the antioxidant activity, and the higher the value, the higher the antioxidant effect is evaluated. Experimental conditions (severe condition test: oxidation induced by leaving at 40℃ for 1 week) are as follows.
① 용매 - 에탄올① Solvent - Ethanol
② 함량 - 0.01 wt% 분산액, 0.02 wt% 분산액② Content - 0.01 wt% dispersion, 0.02 wt% dispersion
③ 방법 - shaking waterbath 사용. 30℃, 2hr③ Method - Use a shaking water bath. 30℃, 2hr
④ 필터 - No.5 여과지 사용 자연여과후 0.45μm 카트리지 필터 사용④ Filter - Use No.5 filter paper, use 0.45μm cartridge filter after natural filtration
실험 결과는 아래 표 6 및 표 7에 나타내었다. The experimental results are shown in Tables 6 and 7 below.
구분　division 제조예 1Preparation Example 1 실시예 1Example 1 실시예 2Example 2 비교예 1Comparative Example 1 비교예 2Comparative Example 2 비교예 3Comparative Example 3 비교예 4Comparative Example 4
0.01 wt%0.01 wt% 83.183.1 28.828.8 33.533.5 19.719.7 25.425.4 15.115.1 20.520.5
0.02 wt%0.02 wt% 94.394.3 50.150.1 58.258.2 38.338.3 44.644.6 33.733.7 40.940.9
구분　division 실시예 3Example 3 실시예 4Example 4 비교예 5Comparative Example 5 비교예 6Comparative Example 6 비교예 7Comparative Example 7 비교예 8Comparative Example 8
0.01 wt%0.01 wt% 45.345.3 52.452.4 32.632.6 40.840.8 25.325.3 35.235.2
0.02 wt%0.02 wt% 71.571.5 80.380.3 55.255.2 62.562.5 46.246.2 57.757.7
상기 표 6 및 표 7에 나타낸 바와 같이, 수용성 항산화 유화물에 카테킨이나 토코페롤을 포함하지 않은 제조예 3, 제조예 4의 수용성 항산화 유화물을 사용하는 경우 알칼로이드 함유 수용성 유화 조성물의 항산화 효과가 낮은 것을 확인할 수 있었다. As shown in Tables 6 and 7, when the water-soluble antioxidant emulsions of Preparation Examples 3 and 4 that do not contain catechin or tocopherol in the water-soluble antioxidant emulsions are used, it can be confirmed that the antioxidant effect of the water-soluble emulsion composition containing alkaloids is low. there was.
실험예Experimental example 2: 수용해도 확인 2: Confirm water solubility
하기 표 8 및 표 11에 기재된 조성에 따라 알칼로이드 유화물에 수용성 항산화제 유화물을 투입한 후 유화액의 성상을 확인하면서 500 rpm 이하에서 혼합 분산 작업을 진행하여 수용성 항산화제 유화물을 함유하는 알칼로이드 함유 수용성 유화 조성물을 제조하였다. After adding the water-soluble antioxidant emulsion to the alkaloid emulsion according to the compositions shown in Tables 8 and 11 below, mixing and dispersing at 500 rpm or less while confirming the properties of the emulsion is performed, and an alkaloid-containing water-soluble emulsion composition containing the water-soluble antioxidant emulsion was prepared.
제조된 알칼로이드 함유 수용성 유화 조성물의 수용해도를 아래와 같이 확인하였다. 증류수 50 ml를 항온수조에서 수온 38 ℃를 유지하고, 100 rpm 속도를 유지하면서 실시예와 비교예의 유화 조성물을 1g을 투입하였다. 1시간 후 원심분리 후 여과한 다음 Karl Fisher method 로 수분함량 측정하여 유기물 함량 정량하였다. The aqueous solubility of the prepared alkaloid-containing water-soluble emulsion composition was confirmed as follows. 50 ml of distilled water was added to the emulsion composition of Examples and Comparative Examples while maintaining a water temperature of 38° C. in a constant temperature water bath and maintaining a speed of 100 rpm. After 1 hour, centrifugation was followed by filtration, and the water content was measured by Karl Fisher method to quantify the organic matter content.
구분
(중량%)division
(weight%) 		실시예
1Example
One 		비교예
33comparative example
33 		비교예
34comparative example
34 		비교예
35comparative example
35 		비교예 36Comparative Example 36 비교예 37Comparative Example 37 비교예 38Comparative Example 38 비교예 39Comparative Example 39
수용성 항산화제 유화물Water Soluble Antioxidant Emulsion 제조예 1
(1wt%)Preparation Example 1
(1wt%) 		제조예 1
(1wt%)Preparation Example 1
(1wt%) 		제조예 1
(1wt%)Preparation Example 1
(1wt%) 		제조예 1
(1wt%)Preparation Example 1
(1wt%) 		제조예 1
(1wt%)Preparation Example 1
(1wt%) 		제조예 1
(1wt%)Preparation Example 1
(1wt%) 		제조예 2
(1wt%)Preparation 2
(1wt%) 		제조예 5
(1wt%)Preparation 5
(1wt%)
피페린
유화물piperine
emulsion 		제조예 9
(99wt%)Preparation 9
(99wt%) 		제조예 10
(99wt%) Preparation 10
(99wt%) 		제조예 11
(99wt%)Preparation 11
(99wt%) 		제조예 12
(99wt%)Preparation 12
(99wt%) 		제조예 13
(99wt%)Preparation 13
(99wt%) 		제조예 14
(99wt%)Preparation 14
(99wt%) 		제조예 9
(99wt%)Preparation 9
(99wt%) 		제조예 9
(99wt%)Preparation 9
(99wt%)
구분
(중량%)division
(weight%) 		비교예
40comparative example
40 		비교예
41comparative example
41 		비교예
42comparative example
42
수용성 항산화제 유화물Water Soluble Antioxidant Emulsion 제조예 6
(1wt%)Preparation 6
(1wt%) 		제조예 7
(1wt%)Preparation 7
(1wt%) 		제조예
8
(1wt%)production example
8
(1wt%)
피페린 유화물piperine emulsion 제조예 9
(99wt%)Preparation 9
(99wt%) 		제조예 9
(99wt%)Preparation 9
(99wt%) 		제조예 9
(99wt%)Preparation 9
(99wt%)
구분
(중량%)division
(weight%) 		실시예
3Example
3 		비교예
43comparative example
43 		비교예
44comparative example
44 		비교예
45comparative example
45 		비교예 46Comparative Example 46 비교예 47Comparative Example 47 비교예 48Comparative Example 48 비교예 49Comparative Example 49
수용성 항산화제 유화물Water Soluble Antioxidant Emulsion 제조예 1
(1wt%)Preparation Example 1
(1wt%) 		제조예 1
(1wt%)Preparation Example 1
(1wt%) 		제조예 1
(1wt%)Preparation Example 1
(1wt%) 		제조예 1
(1wt%)Preparation Example 1
(1wt%) 		제조예 1
(1wt%)Preparation Example 1
(1wt%) 		제조예 1
(1wt%)Preparation Example 1
(1wt%) 		제조예 2
(1wt%)Preparation 2
(1wt%) 		제조예 5
(1wt%)Preparation 5
(1wt%)
캡사이신 유화물capsaicin emulsion 제조예 15
(99wt%)Preparation 15
(99wt%) 		제조예 16
(99wt%)Preparation 16
(99wt%) 		제조예 17
(99wt%)Preparation 17
(99wt%) 		제조예 18
(99wt%)Preparation 18
(99wt%) 		제조예 19
(99wt%)Preparation 19
(99wt%) 		제조예 20
(99wt%)Preparation 20
(99wt%) 		제조예 15
(99wt%)Preparation 15
(99wt%) 		제조예 15
(99wt%)Preparation 15
(99wt%)
구분
(중량%)division
(weight%) 		비교예
50comparative example
50 		비교예
51comparative example
51 		비교예
52comparative example
52
수용성 항산화제 유화물Water Soluble Antioxidant Emulsion 제조예 6
(1wt%)Preparation 6
(1wt%) 		제조예 7
(1wt%)Preparation 7
(1wt%) 		제조예 8
(1wt%)Preparation 8
(1wt%)
캡사이신 유화물capsaicin emulsion 제조예 15
(99wt%)Preparation 15
(99wt%) 		제조예 15
(99wt%)Preparation 15
(99wt%) 		제조예 15
(99wt%)Preparation 15
(99wt%)
구분division 실시예 1Example 1 비교예 33Comparative Example 33 비교예 34Comparative Example 34 비교
예 35compare
Example 35 		비교예 36Comparative Example 36 비교예 37Comparative Example 37 비교예 38Comparative Example 38 비교예 39Comparative Example 39 비교예 40Comparative Example 40 비교예 41Comparative Example 41 비교예 42Comparative Example 42
수용해도(%)Water solubility (%) 99.399.3 15.615.6 10.910.9 16.916.9 20.820.8 12.212.2 13.713.7 19.719.7 11.911.9 14.614.6 23.723.7
구분division 일반 분말형 피페린Generic powdered piperine 일반 분말형 캡사이신Generic powdered capsaicin
수용해도(%)Water solubility (%) 0.0040.004 0.0010.001
구분division 실시예 3Example 3 비교예 43Comparative Example 43 비교예 44Comparative Example 44 비교예 45Comparative Example 45 비교예 46Comparative Example 46 비교예 47Comparative Example 47 비교예 48Comparative Example 48 비교예 49Comparative Example 49 비교예 50Comparative Example 50 비교예 51Comparative Example 51 비교예 52Comparative Example 52
수용해도
(%)water solubility
(%) 		96.896.8 9.89.8 8.28.2 11.811.8 14.214.2 10.710.7 9.69.6 14.414.4 10.110.1 10.810.8 15.915.9
상기 표 12 내지 표 14에 나타낸 바와 같이, HLB(Hydrophile-Lipophile Balance)가 상이한 2종의 계면활성제를 포함하는 수용성 항산화 유화물과 알칼로이드 유화물을 사용한 실시예 1 내지 15의 조성물은 비교예의 유화물과 비교하여 수용해도가 매우 높은 것으로 나타났다. As shown in Tables 12 to 14, the compositions of Examples 1 to 15 using water-soluble antioxidant emulsions and alkaloid emulsions containing two types of surfactants having different HLB (Hydrophile-Lipophile Balance) were compared with the emulsions of Comparative Examples. The water solubility was found to be very high.
실험예Experimental example 3: 3: 수분산water dispersion 유화 입자 확인 Confirmation of emulsified particles
상기 표 8 및 표 11에 따라 제조된 알칼로이드 함유 수용성 유화 조성물의 유화 입자 크기를 아래와 같이 확인하였다. 증류수 50 ml를 항온수조에서 수온 38 ℃를 유지하고, 100 rpm 속도를 유지하면서 실시예와 비교예의 유화 조성물을 1g을 투입하였다. 1시간 후 광학현미경으로 유화 입자를 관찰하고 그 결과를 도 1 및 도 2에 나타내었다. The emulsified particle size of the alkaloid-containing water-soluble emulsion composition prepared according to Tables 8 and 11 was confirmed as follows. 50 ml of distilled water was added to the emulsion composition of Examples and Comparative Examples while maintaining a water temperature of 38° C. in a constant temperature water bath and maintaining a speed of 100 rpm. After 1 hour, the emulsified particles were observed under an optical microscope, and the results are shown in FIGS. 1 and 2 .
Zetasizer Nano ZS(Malvern Instrument, U.K.)를 사용하여 상기 증류수 중 유화입자의 크기를 측정하였다. 이때 시료에 대하여 3회 반복 측정하였고, 그 평균값을 하기 표 15에 나타내었다. The size of the emulsified particles in the distilled water was measured using a Zetasizer Nano ZS (Malvern Instrument, U.K.). At this time, the sample was repeatedly measured three times, and the average value is shown in Table 15 below.
구분division 실시예
1Example
One 		실시예
3Example
3
유화입자크기
(μm)Emulsion particle size
(μm) 		2.322.32 3.383.38
상기 표 15, 도 1 및 도 2를 참조하면, 본 발명의 일 실시예에 해당하는 알칼로이드 함유 수용성 유화 조성물은 1.0 내지 5.0 μm의 유화 입자를 형성하는 반면, 비교예 33 내지 52의 알칼로이드 함유 수용성 유화 조성물은 유화 입자가 형성되지 않아 유화입자의 크기를 측정할 수 없었다. 이로부터 본 발명에 따른 알칼로이드 함유 수용성 유화 조성물은 생체에서 흡수되어 높은 생체이용률을 나타낼 수 있을 것으로 예상할 수 있다. Referring to Table 15, FIGS. 1 and 2, the alkaloid-containing water-soluble emulsion composition according to an embodiment of the present invention forms emulsified particles of 1.0 to 5.0 μm, while the alkaloid-containing water-soluble emulsion composition of Comparative Examples 33 to 52 The composition did not form emulsified particles, so the size of the emulsified particles could not be measured. From this, it can be expected that the alkaloid-containing water-soluble emulsion composition according to the present invention can be absorbed in the body and exhibit high bioavailability.

Claims (7)

  1. (1) 전체 100 중량%를 만족하도록 하기 성분을 포함하는 수용성 항산화제 유화물: (1) A water-soluble antioxidant emulsion comprising the following ingredients to satisfy 100% by weight of the total:
    토코페롤 1 내지 40 중량%,1 to 40% by weight of tocopherol,
    카테킨 1 내지 40 중량%,1 to 40% by weight of catechin,
    HLB 3 내지 HLB 7의 제1 계면활성제 1 내지 30 중량%,1 to 30% by weight of a first surfactant of HLB 3 to HLB 7,
    HLB 10 내지 HLB 14의 제2 계면활성제 10 내지 80 중량%;10 to 80% by weight of a second surfactant of HLB 10 to HLB 14;
    공계면활성제 10 내지 45 중량%, 및10 to 45% by weight of a cosurfactant, and
    식용 유지 1 내지 35 중량%,1 to 35% by weight of edible oil,
    (2) 전체 100 중량%를 만족하도록 하기 성분을 포함하는 알칼로이드 유화물:(2) an alkaloid emulsion comprising the following components to satisfy the total 100% by weight:
    알칼로이드 1 내지 30 중량%,1 to 30% by weight of an alkaloid;
    HLB 3 내지 HLB 7의 제1 계면활성제 1 내지 10 중량%,1 to 10% by weight of a first surfactant of HLB 3 to HLB 7,
    HLB 10 내지 HLB 14의 제2 계면활성제 1 내지 20 중량%, 및1 to 20% by weight of a second surfactant of HLB 10 to HLB 14, and
    공계면활성제 40 내지 97 중량%, 40 to 97% by weight of co-surfactant,
    를 포함하는, 수용성 항산화제 유화물을 함유하는 알칼로이드 함유 수용성 유화 조성물.An alkaloid-containing water-soluble emulsion composition comprising a water-soluble antioxidant emulsion.
  2. 제1항에 있어서, 상기 알칼로이드 함유 수용성 유화 조성물은The method of claim 1, wherein the alkaloid-containing water-soluble emulsion composition is
    상기 수용성 항산화제 유화물 0.1 내지 20 중량%; 및0.1 to 20% by weight of the water-soluble antioxidant emulsion; and
    상기 알칼로이드 유화물 80 내지 99.9 중량%80 to 99.9 wt% of the alkaloid emulsion
    를 포함하는 것인, 수용성 항산화제 유화물을 함유하는 알칼로이드 함유 수용성 유화 조성물.A water-soluble emulsion composition containing an alkaloid containing a water-soluble antioxidant emulsion comprising a.
  3. 제1항 또는 제2항에서, 상기 알칼로이드는3. The method of claim 1 or 2, wherein the alkaloid is
    피페린, 캡사이신, 및 이들의 혼합물로 이루어진 군에서 선택된 1종인 것인, 수용성 항산화제 유화물을 함유하는 알칼로이드 함유 수용성 유화 조성물.An alkaloid-containing water-soluble emulsion composition containing a water-soluble antioxidant emulsion, which is one selected from the group consisting of piperine, capsaicin, and mixtures thereof.
  4. 제1항 또는 제2항에서, 상기 제1 계면활성제는The method of claim 1 or 2, wherein the first surfactant is
    글리세린 지방산 에스테르, 폴리글리세린 지방산 에스테르, 솔비탄 지방 에스테르, 레시틴, 프로필렌글리콜 지방산 에스테르 및 이들의 혼합물로 이루어진 군에서 선택된 1종인 것인, 수용성 항산화제 유화물을 함유하는 알칼로이드 함유 수용성 유화 조성물.An alkaloid-containing water-soluble emulsion composition containing a water-soluble antioxidant emulsion, which is one selected from the group consisting of glycerin fatty acid ester, polyglycerin fatty acid ester, sorbitan fatty ester, lecithin, propylene glycol fatty acid ester, and mixtures thereof.
  5. 제1항 또는 제2항에서, 상기 제2 계면활성제는The method of claim 1 or 2, wherein the second surfactant is
    폴리글리세린 지방산 에스테르, 폴리옥시에틸렌 솔비탄 지방산 에스테르, 자당 지방산 에스테르, 효소분해 레시틴 및 이들의 혼합물로 이루어진 군에서 선택된 1종인 것인, 수용성 항산화제 유화물을 함유하는 알칼로이드 함유 수용성 유화 조성물.An alkaloid-containing water-soluble emulsion composition containing a water-soluble antioxidant emulsion, which is one selected from the group consisting of polyglycerol fatty acid ester, polyoxyethylene sorbitan fatty acid ester, sucrose fatty acid ester, enzymatically decomposed lecithin, and mixtures thereof.
  6. 제1항 또는 제2항에서, 상기 공계면활성제는The method of claim 1 or 2, wherein the co-surfactant is
    글리세린, 솔비톨, 폴리에틸렌글리콜, 프로필렌글리콜, 트리아세틴 및 이들의 혼합물로 이루어진 군에서 선택된 1종인 것인, 수용성 항산화제 유화물을 함유하는 알칼로이드 함유 수용성 유화 조성물.An alkaloid-containing water-soluble emulsion composition containing a water-soluble antioxidant emulsion, which is one selected from the group consisting of glycerin, sorbitol, polyethylene glycol, propylene glycol, triacetin, and mixtures thereof.
  7. 제1항 또는 제2항에서, 상기 식용 유지는The method of claim 1 or 2, wherein the edible oil is
    두유, 옥수수유, 채종유, 고올레산 채종유, 홍화유, 미강유, 팜유, 올리브유, 해바라기유, 야자유, 소맥 배아유, 중쇄중성지방(MCT Oil)에서 선택된 1종 이상의 식용 유지인 것인, 수용성 항산화제 유화물을 함유하는 알칼로이드 함유 수용성 유화 조성물.Soymilk, corn oil, rapeseed oil, high oleic rapeseed oil, safflower oil, rice bran oil, palm oil, olive oil, sunflower oil, palm oil, wheat germ oil, and at least one edible oil selected from medium chain neutral fat (MCT Oil), water-soluble antioxidant emulsion An alkaloid-containing water-soluble emulsion composition containing
PCT/KR2021/018432 2020-12-15 2021-12-07 Alkaloid-containing, water-soluble emulsified composition WO2022131656A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
KR10-2020-0174987 2020-12-15
KR1020200174987A KR102524312B1 (en) 2020-12-15 2020-12-15 Water-soluble emulsion composition comprising ecdysteroid
KR10-2021-0026166 2021-02-26
KR1020210026166A KR20220122840A (en) 2021-02-26 2021-02-26 Water-soluble emulsion composition comprising alkaloids

Publications (1)

Publication Number Publication Date
WO2022131656A1 true WO2022131656A1 (en) 2022-06-23

Family

ID=82059214

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2021/018432 WO2022131656A1 (en) 2020-12-15 2021-12-07 Alkaloid-containing, water-soluble emulsified composition

Country Status (1)

Country Link
WO (1) WO2022131656A1 (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07227227A (en) * 1993-12-20 1995-08-29 Sanei Gen F F I Inc Stable emulsified composition and food containing the same
KR100359044B1 (en) * 1993-07-08 2003-02-05 노파르티스 아게 Pharmaceutical Compositions for Hardly Soluble Active Substances
US20070087104A1 (en) * 2005-10-14 2007-04-19 Wild Flavors, Inc. Microemulsions for use in food and beverage products
JP2011252015A (en) * 2003-05-22 2011-12-15 Lipocine Inc Pharmaceutical composition and dosage form for administration of hydrophobic drug
JP2013159730A (en) * 2012-02-07 2013-08-19 Ogawa & Co Ltd Oil-soluble antioxidant and method for producing the same

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100359044B1 (en) * 1993-07-08 2003-02-05 노파르티스 아게 Pharmaceutical Compositions for Hardly Soluble Active Substances
JPH07227227A (en) * 1993-12-20 1995-08-29 Sanei Gen F F I Inc Stable emulsified composition and food containing the same
JP2011252015A (en) * 2003-05-22 2011-12-15 Lipocine Inc Pharmaceutical composition and dosage form for administration of hydrophobic drug
US20070087104A1 (en) * 2005-10-14 2007-04-19 Wild Flavors, Inc. Microemulsions for use in food and beverage products
JP2013159730A (en) * 2012-02-07 2013-08-19 Ogawa & Co Ltd Oil-soluble antioxidant and method for producing the same

Similar Documents

Publication Publication Date Title
US20240091192A1 (en) Dilutable formulations of cannabinoids and processes for their preparation
DE69920668T2 (en) CYCLOSPORIN OR MACROLIDE CONTAINING EMULSION PRECONCENTRATES
DE60018372T2 (en) ORAL COMPOSITION AS MICROEMULSION OF SILYBIN
KR101068253B1 (en) Pharmaceutical compositions comprising cyclosporin for oral administration
DE3237814A1 (en) WATER-FREE EMULSIONS AND USE THEREOF
US4325965A (en) Agent for preventing or treating psoriasis
EP0456106B1 (en) Stable emulsion for pharmaceutical administration, process for its preparation and use thereof as pharmaceutical
EP1028722B1 (en) Pharmaceutically active composition containing artemisinine and/or a derivative of artemisinine
WO2012150839A2 (en) Method for microencapsulating phosphatidylserine
WO2022131656A1 (en) Alkaloid-containing, water-soluble emulsified composition
KR101068256B1 (en) Oral pharmaceutical compositions comprising cyclosporin
WO2018105755A1 (en) Cosmetics containing nanoparticles having encapsulated therein whitening-improving active ingredient, and method for producing said cosmetics
WO2021040233A1 (en) Cosmetic composition comprising calamine dispersed in biopolymer, and sheet mask using same
WO2022131654A1 (en) Water-soluble emulsion composition containing ecdysteroid
WO2022131653A1 (en) Water-soluble emulsion composition containing natural polyphenol compound
WO2018044035A1 (en) Oil-in-water type cosmetic composition
KR20220122840A (en) Water-soluble emulsion composition comprising alkaloids
CN112022860A (en) Anti-inflammatory composition, preparation method and application
DE69914077T2 (en) PIPERIDINE SUBSTANCE P ANTAGONIST EMULSION PRECONCENTRATES
KR102583074B1 (en) Water-soluble emulsion composition comprising natural polyphenolic compound
EP0464274B1 (en) Soft gelatin capsule
CN113845677A (en) Emulsion film and preparation method thereof
WO2018111021A1 (en) Ophthalmic composition containing sulfasalazine and hyaluronic acid
DE60017720T2 (en) PHARMACEUTICAL EMULSIONS FOR RETROVIRAL-PROTEASE-INHIBITING COMPOUNDS
RU2321404C1 (en) Pharmaceutical composition designated for oral administration of pyrazole-3-carboxamide derivative

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 21906960

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205N DATED 08.08.2023)